Healthcare provider profile · identity verified

Eric James Bailey, D.O.

Family Practice · COLUMBIA, PA · NPI 1851845671

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	645	216
Amlodipine Besylate	Amlodipine Besylate	429	130
Lisinopril	Lisinopril	358	113
Rosuvastatin Calcium	Rosuvastatin Calcium	335	115
Levothyroxine Sodium	Levothyroxine Sodium	251	69
Metformin Hcl	Metformin Hcl	228	73
Losartan Potassium	Losartan Potassium	177	53
Omeprazole	Omeprazole	165	50
Gabapentin	Gabapentin	164	46
Ozempic	Semaglutide	155	23
Tamsulosin Hcl	Tamsulosin Hcl	148	44
Albuterol Sulfate Hfa	Albuterol Sulfate	122	36
Simvastatin	Simvastatin	121	36
Metoprolol Succinate	Metoprolol Succinate	117	38
Ezetimibe	Ezetimibe	105	38
Famotidine	Famotidine	97	32
Jardiance	Empagliflozin	96	30
Pantoprazole Sodium	Pantoprazole Sodium	96	32
Chlorthalidone	Chlorthalidone	92	24
Alendronate Sodium	Alendronate Sodium	89	32
Valsartan	Valsartan	89	29
Trazodone Hcl	Trazodone Hcl	83	26
Diclofenac Sodium	Diclofenac Sodium	81	32
Naproxen	Naproxen	78	27
Eliquis	Apixaban	74	19
Furosemide	Furosemide	74	30
Clopidogrel	Clopidogrel Bisulfate	73	24
Metformin Hcl Er	Metformin Hcl	72	26
Atenolol	Atenolol	70	22
Hydrochlorothiazide	Hydrochlorothiazide	69	26
Spironolactone	Spironolactone	68	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	22
Carvedilol	Carvedilol	65	23
Metoprolol Tartrate	Metoprolol Tartrate	63	25
Meloxicam	Meloxicam	62	17
Escitalopram Oxalate	Escitalopram Oxalate	61	21
Pioglitazone Hcl	Pioglitazone Hcl	60	18
Montelukast Sodium	Montelukast Sodium	58	19
Glipizide Er	Glipizide	55	15
Sertraline Hcl	Sertraline Hcl	55	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	53	43
Fluticasone Propionate	Fluticasone Propionate	50	22
Trulicity	Dulaglutide	50	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	suppressed
Warfarin Sodium	Warfarin Sodium	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	44	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	37
Bupropion Xl	Bupropion Hcl	42	14
Finasteride	Finasteride	42	11
Januvia	Sitagliptin Phosphate	41	15
Potassium Chloride	Potassium Chloride	41	13
Triamcinolone Acetonide	Triamcinolone Acetonide	41	22
Alprazolam	Alprazolam	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	39	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	39	28
Xarelto	Rivaroxaban	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Allopurinol	Allopurinol	37	11
Pravastatin Sodium	Pravastatin Sodium	34	13
Tramadol Hcl	Tramadol Hcl	34	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	32	32
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Glimepiride	Glimepiride	30	11
Prednisone	Prednisone	30	27
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Bumetanide	Bumetanide	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Ventolin Hfa	Albuterol Sulfate	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	19
Azithromycin	Azithromycin	20	17
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Repaglinide	Repaglinide	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	18	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Primidone	Primidone	15	suppressed
Glipizide	Glipizide	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triazolam	Triazolam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error